Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
International Journal of Hematology
|
January 20, 2011
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
Joseph Pidala, Jaime Roman-Diaz, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 11, 2011
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation
Joseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Bone Marrow Transplantation
|
April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease
Lia Perez, Hugo Fernandez, Pedro Horna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 2, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting
Mohamed A Kharfan-Dabaja, Claudio Anasetti, Hugo F Fernandez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2015
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results
Joseph Pidala, Jongphil Kim, Brian C Betts, et al.
Haematologica
|
April 5, 2015
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala, Jongphil Kim, Melissa Alsina, et al.
Leukemia Research
|
July 15, 2011
Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review
Jane Jijun Liu, Ling Zhang, Ernesto Ayala, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
Mohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Mohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
International Journal of Hematology
|
January 20, 2011
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications
Joseph Pidala, Jaime Roman-Diaz, Jongphil Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 11, 2011
ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation
Joseph Pidala, Marcie Tomblyn, Taiga Nishihori, et al.
Bone Marrow Transplantation
|
April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease
Lia Perez, Hugo Fernandez, Pedro Horna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 2, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting
Mohamed A Kharfan-Dabaja, Claudio Anasetti, Hugo F Fernandez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2015
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results
Joseph Pidala, Jongphil Kim, Brian C Betts, et al.
Haematologica
|
April 5, 2015
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala, Jongphil Kim, Melissa Alsina, et al.
Leukemia Research
|
July 15, 2011
Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review
Jane Jijun Liu, Ling Zhang, Ernesto Ayala, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
Mohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Mohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Page
of 4